Clinical trial evidence supporting lithium aspartate therapy for slowing Alzheimer’s and Parkinson’s скачать в хорошем качестве

Clinical trial evidence supporting lithium aspartate therapy for slowing Alzheimer’s and Parkinson’s

Dr. Tom Guttuso, MD, Professor of Neurology at the University at Buffalo (https://medicine.buffalo.edu/faculty/...) (@DoctorTomNeurologist) explains the novel results from a recent clinical trial in patients with Parkinson’s disease and why these results imply that lithium aspartate therapy may be protecting brain cells from dying, slowing the progressive worsening of symptoms and disability, and protecting patients’ futures https://www.medrxiv.org/content/10.11.... These potential valuable benefits stem from lithium aspartate’s ability to significantly decrease a very important blood biomarker called neurofilament light and apply to both Parkinson’s (https://movementdisorders.onlinelibra...) and Alzheimer’s disease (https://academic.oup.com/brain/articl...) patients. For those who wish to learn more about all of the evidence supporting lithium to potentially prevent and slow Alzheimer's and Parkinson's, Dr. Tom's book, "The Promise of Lithium: How an Over-the-Counter Supplement May Prevent and Slow Alzheimer's and Parkinson's Disease", can be found here: https://www.amazon.com/Promise-Lithiu... Dr. Tom is also President and majority owner of e3 Pharmaceuticals (e3) (https://www.e3pharmaceuticals.com), which manufactures a NSF-certified lithium aspartate dietary supplement (https://lithitate.com). A primary mission of e3 is to support charity and medical research by devoting 50% of all profits to these endeavors. Disclaimer: The statements made in this video and in the above title and description have not been evaluated by the US Food and Drug Administration (FDA). Dietary supplements, including lithium aspartate, are not intended to diagnose, treat, cure or prevent any disease. Dr. Tom does not personally recommend that anyone take lithium dietary supplements.